Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion type Assertion NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_head.
- NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion description "[Finally, following an observation that the AD-associated mediator, PGD(2), upregulated AKR1C3 expression in PHKs, we used immunofluorescence to examine AKR1C3 expression in AD and psoriasis lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_provenance.
- NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion evidence source_evidence_literature NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_provenance.
- NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion SIO_000772 22170488 NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_provenance.
- NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion wasDerivedFrom befree-20140225 NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_provenance.
- NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_assertion wasGeneratedBy ECO_0000203 NP548263.RADKrn1A8JdwXf2Seoj-eOOr3VlTi-O0OgqK5hSvBiTGA130_provenance.